CMC Regulatory Expectations for Biological Therapeutic Products for Life Cycle Management and EUA Applications, a CDER/FDA Perspective

Speaker Presentation Jing Xianghong (Emily), CDER, FDA, 2021
CMC Regulatory Expectations for Biological Therapeutic Products for Life Cycle Management and EUA Applications, a CDER/FDA Perspective